DECREASE EXPRESSION OF BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR IN SSC TISSUES AND IN ENDOTHELIAL CELLS LEADING TO ENHANCED SUSCEPTIBILITY TO APOPTOSIS
Effect of selective and dual endothelin receptor antagonists (ERAs) on SSc and normal endothelial cells apoptosis
